Robert Chatwani Sells 1,683 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) insider Robert Chatwani sold 1,683 shares of the firm’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $70.87, for a total transaction of $119,274.21. Following the completion of the transaction, the insider owned 68,496 shares in the company, valued at approximately $4,854,311.52. The trade was a 2.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Robert Chatwani also recently made the following trade(s):

• On Wednesday, December 17th, Robert Chatwani sold 13,818 shares of Docusign stock. The shares were sold at an average price of $68.33, for a total transaction of $944,183.94.
• On Thursday, December 11th, Robert Chatwani sold 983 shares of Docusign stock. The stock was sold at an average price of $68.62, for a total transaction of $67,453.46.

Docusign Stock Up 2.4%

Shares of NASDAQ DOCU opened at $69.40 on Friday. The firm’s 50-day moving average price is $68.93 and its two-hundred day moving average price is $74.18. Docusign Inc. has a 52-week low of $63.41 and a 52-week high of $99.30. The stock has a market capitalization of $13.90 billion, a P/E ratio of 48.53, a P/E/G ratio of 3.40 and a beta of 0.98.

Analysts Set New Price Targets

A number of research analysts recently issued reports on DOCU shares. UBS Group reduced their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Wells Fargo & Company reduced their price target on shares of Docusign from $85.00 to $75.00 and set an “equal weight” rating for the company in a report on Friday, December 5th. JPMorgan Chase & Co. lowered their price target on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Citigroup increased their price objective on shares of Docusign from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Thursday, September 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Docusign in a research note on Wednesday, October 8th. Six research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the stock. According to data from MarketBeat, Docusign currently has a consensus rating of “Hold” and a consensus price target of $86.80.

Hedge Funds Weigh In On Docusign

Institutional investors and hedge funds have recently bought and sold shares of the stock. Banque Transatlantique SA bought a new stake in shares of Docusign during the 1st quarter worth about $26,000. Summit Securities Group LLC acquired a new position in shares of Docusign during the first quarter valued at approximately $34,000. Rise Advisors LLC increased its stake in shares of Docusign by 864.6% during the first quarter. Rise Advisors LLC now owns 463 shares of the company’s stock valued at $38,000 after acquiring an additional 415 shares during the period. WPG Advisers LLC acquired a new position in shares of Docusign during the 1st quarter valued at $39,000. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in shares of Docusign in the 2nd quarter worth $43,000. Institutional investors own 77.64% of the company’s stock.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.